A plant sulfur compound from papaya seed, garden cress, and watercress that activates the body's antioxidant and waste-clearing defenses. Cell and animal work suggests anti-cancer, anti-obesity, and fatty-liver benefits, but no human trials exist. Modest amounts from food fit a protective eating pattern; concentrated extracts carry an ill-defined safety margin and unproven value. Early-stage. (Full Review)

Protocol

Source

Whole foods

Garden cress, watercress, nasturtium, mustard, papaya seed

Preparation

Raw or lightly processed

Myrosinase must act on glucosinolates to form BITC; pair cooked crucifers with a raw source or chew thoroughly

Frequency

Split across the day, with meals

Rapid clearance favors repeated modest intake over single large doses

Time to effect

Enzyme induction

Hours to days

Detoxification-enzyme activity rises within hours to a few days; no human clinical time course documented

Benefits

Medium: Cancer risk reduction as a dietary isothiocyanate

Low: Metabolic and anti-obesity effects, anti-inflammatory activity, liver protection in fatty liver, antimicrobial and antifungal activity

Speculative: Senolytic activity, cardiac regeneration, neuroprotection and cognitive support

Contraindications

Pregnancy and breastfeeding

Children

Active or prior bladder cancer or chronic bladder disease

Diagnosed thyroid disease or significant iodine deficiency

Moderate-to-severe kidney impairment (eGFR under 60 mL/min/1.73m²)

Key Interactions

Prescription drugs metabolized via CYP3A4 or glutathione (some chemotherapy agents, statins such as simvastatin, sedatives such as midazolam)

High-dose acetaminophen (paracetamol)

N-acetylcysteine and glutathione supplements

Other dietary isothiocyanates (sulforaphane, phenethyl isothiocyanate) and cruciferous compounds

Concurrent high iodine restriction

Risk & Side Effects

Medium: Urinary bladder toxicity and tumor promotion at high doses

Low: Gastrointestinal and mucosal irritation, thyroid hormone suppression, renal stress at high doses, hematologic changes and reduced weight gain

Speculative: Pro-oxidant effects and glutathione depletion, interference with drug metabolism

Monitoring

Marker	Target	Why
TSH	0.5–2.0 mIU/L	Detects thyroid suppression from the goitrogenic effect
Free T4	1.0–1.5 ng/dL	Confirms adequate active thyroid hormone if TSH shifts
Free T3	3.0–4.2 pg/mL	Reflects the most active thyroid hormone, sensitive to suppression
eGFR	>90 mL/min/1.73m²	Screens for the renal strain seen at high animal doses
Urinalysis (urine protein)	Negative to trace	Detects early bladder/kidney irritation, the key safety signal
ALT	<25 U/L	Screens liver stress given hepatic metabolism
hs-CRP	<1.0 mg/L	Tracks systemic inflammation, a mechanistic target

Cadence: Baseline before concentrated use; retest at 4–6 weeks, then every 6–12 months, with earlier retesting if symptoms arise

Qualitative Assessment

Energy and cold tolerance — new fatigue or cold sensitivity can signal thyroid suppression
Digestive comfort — burning, nausea, or stomach upset suggests mucosal irritation
Urinary symptoms — urgency, discomfort, or blood in the urine is a signal to stop
Overall well-being — general vitality and cognitive clarity gauge tolerance

BITC for Health & Longevity

Protocol

Benefits

Risk & Side Effects

Monitoring

Qualitative Assessment